NEW YORK (GenomeWeb) – Empire Genomics announced today that it has partnered with Kromatid to develop tools to help researchers detect and understand genomic structural variations of cancer patients.

The companies will combine Empire's next-generations sequencing services, FISH probe portfolio, and CLIA-certified laboratory with Kromatid's Pinpoint probes and new directional genomic hybridization technology — a tool capable of detecting and visualizing structural variations as low as 3Kb at the single-cell level.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.